Category - Features

Features

Helius Medical rolling out PoNS treatment for mmTBI in Canada

Helius Medical Technologies (NASDAQ:HSDT; TSX:HSM) is transitioning from a development- to commercial-stage company as it rolls out its Health Canada-cleared PoNS medical device for the treatment of chronic balance...

July 2, 2019

Features

Chardan president, Jonas Grossman, talks SPACs

Jonas Grossman As president of Chardan, an independent, global investment bank specializing in healthcare, disruptive technologies, and special purpose acquisition companies (SPACs), Jonas Grossman takes a worldwide...

June 25, 2019

Features

Zenabis sets sights on becoming leading cannabis producer

Andrew Grieve, CEO Despite being a new entrant in the cannabis market, Zenabis Global (TSX:ZENA) is making huge strides to become one of the largest licensed producers of medical and adult-use recreational cannabis in...

June 11, 2019

Features

XORTX awaiting key clinical milestones in treating progressive kidney diseases

XORTX Therapeutics (CSE:XRX; OTCQB:XRTXF) is awaiting several key milestones during the next few months as it works to redefine how progressive kidney disease is treated. “Our two lead programs are targeting uric acid...

June 4, 2019

Features

Oragenics developing novel therapeutics using synthetic bacteria

Oragenics (NYSE American: OGEN) is leveraging its synthetic biology platforms to address two significant unmet medical needs: oral mucositis (OM) and multi drug-resistant (MDR) bacterial infections. According to the...

May 28, 2019

Features

BriaCell advancing potential breakthrough immunotherapy for advanced breast cancer

BriaCell Therapeutics (TSXV:BCT; OTCQB:BCTXF) has reported impressive early safety and efficacy data with its lead immunotherapies for the treatment of advanced breast cancer. “Right now, there is no immunotherapy that...

May 21, 2019

Features

MediXall transforming patient-healthcare provider experience

MediXall Group (OTCQB:MDXL) has launched a new generation healthcare marketplace platform to address self-pay and high deductible consumers’ growing need for greater healthcare cost transparency and access to...

May 14, 2019

Features

Ceapro transitioning to biopharmaceutical company from contract manufacturer

Ceapro (TSXV:CZO) is transitioning to a new business model – from a contract manufacturer to a biopharmaceutical company – to pursue multiple growth opportunities in nutraceuticals and pharmaceuticals. “As...

May 7, 2019

Features

Leviticus Cardio developing wireless system to drive VADs

Closely-held Leviticus Cardio of Israel is developing a wireless system capable of providing day-to-day power needs for implanted ventricular assist devices (VADs), eliminating the complications that congestive heart...

April 30, 2019

Features

In conversation with Susan Linna of BDO

As managing director, life sciences specialty services at BDO, the global professional services firm, Susan Linna has more than 25 years of drug, vaccine and biologic development experience, 13 of which were at a...

April 23, 2019

Category - Features

Helius Medical rolling out PoNS treatment for mmTBI in Canada

Chardan president, Jonas Grossman, talks SPACs

Zenabis sets sights on becoming leading cannabis producer

XORTX awaiting key clinical milestones in treating progressive kidney diseases

Oragenics developing novel therapeutics using synthetic bacteria

BriaCell advancing potential breakthrough immunotherapy for advanced breast cancer

MediXall transforming patient-healthcare provider experience

Ceapro transitioning to biopharmaceutical company from contract manufacturer

Leviticus Cardio developing wireless system to drive VADs

In conversation with Susan Linna of BDO

Follow Us

Subscribe

General

More

Subscribe